Screening for Postoperative Vital Signs Abnormalities, and Particularly Hemodynamic Ones, by Continuous Monitoring Using the Biobeat Patch

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions
Surgery--Complications
Interventions
DEVICE

Biobeat patch

"The Biobeat device (BB-613WP) is a class IIa medical device and is a non-invasive patch used for monitoring vital signs in clinical and non-clinical settings. The sensor continuously records the photoplethysmographic waveform that allows the calculation of several physiological parameters: heart rate (HR), SPO2, systolic blood pressure (SBP) and change in SBP, diastolic blood pressure (DBP) and change in DBP, stroke volume (SV), cardiac output (CO), cardiac index (CI), systemic vascular resistance (SVR), and respiration rate (RR).~Translated with www.DeepL.com/Translator (free version)"

Trial Locations (2)

75014

Groupe hospitalier Paris Saint-Joseph, Paris

92150

Hopital Foch, Suresnes

All Listed Sponsors
lead

Hopital Foch

OTHER

NCT04585178 - Screening for Postoperative Vital Signs Abnormalities, and Particularly Hemodynamic Ones, by Continuous Monitoring Using the Biobeat Patch | Biotech Hunter | Biotech Hunter